| Financial Year |
March 31 2023 |
| Monetary Funds |
1,455,715,132.06 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
118,021,175.19 |
| Accounts Receivable |
815,238,078.11 |
| Advances to Suppliers |
38,088,989.49 |
| Other Receivables |
200,947,085.96 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
122,000,610.00 |
| Inventories |
766,437,415.32 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
9,198,513.62 |
| Total Current Assets |
3,403,646,389.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,416,966,443.87 |
| Investment Properties |
3,798,028.97 |
| Fixed Assetes |
959,153,212.17 |
| Under-construction Projects |
52,404,049.52 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
147,701,839.87 |
| R&D expenses |
7,951,626.15 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
42,980,557.01 |
| Deferred Income Tax Assets |
113,566,426.65 |
| Other Non-Current Assets |
40,345,594.53 |
| Sub-Total of Non-Current Assets |
3,818,166,814.39 |
| Total Assets |
7,221,813,204.14 |
| Short-Term Loans |
848,462,807.87 |
| Trading Financial liabilities |
-- |
| Notes Payable |
234,732,587.84 |
| Accounts Payable |
763,915,875.15 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
41,999,141.51 |
| Taxes Payable |
13,705,109.37 |
| Interest Payable |
-- |
| Dividend Payable |
2,189,050.00 |
| Other payables |
129,835,083.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
181,589,187.52 |
| Other Current Liabilities |
20,671,435.07 |
| Sub-Total of Current Liabilities |
2,300,872,451.62 |
| Long-term Loans |
450,940,951.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
114,400,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
11,383,200.00 |
| Deferred Income Tax Liabilities |
11,562,787.73 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
604,996,889.19 |
| Total Liabilities |
2,905,869,340.81 |
| Paid-In Capital(Or Share Stock) |
455,225,750.00 |
| Capital Surplus |
1,032,487,949.35 |
| Surplus Reserve |
237,582,942.90 |
| LESS:Treasury Stock |
52,338,680.00 |
| Undistributed Profits |
2,091,487,849.16 |
| Minority Stockholder's Interest |
548,474,427.35 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,767,469,435.98 |
| Owner's Equity（Stockholder's Equity） |
4,315,943,863.33 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,221,813,204.14 |
